DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Oppenheimer Downgrades Alexion Pharmaceuticals to Perform

Oppenheimer analyst Hartaj Singh downgrades Alexion Pharmaceuticals (NASDAQ:ALXN) from Outperform to Perform.

Benzinga · 03/17/2020 14:11

Oppenheimer analyst Hartaj Singh downgrades Alexion Pharmaceuticals (NASDAQ:ALXN) from Outperform to Perform.